Federal Register of Legislation - Australian Government

Primary content

PB 86 of 2010 Specifications as made
This instrument amends the National Health Act (Pharmaceutical Benefits - Early Supply) - specification under subsection 84AAA(2) Instrument 2009 (No. PB 30 of 2009) to amend the list of medicines for which Pharmaceutical Benefits Scheme (PBS) Safety Net entitlements will not apply when the next supply of the same medicine is obtained within 20 days.
Administered by: Health
Registered 12 Aug 2010
Tabling HistoryDate
Tabled HR28-Sep-2010
Tabled Senate28-Sep-2010
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014



Instrument number PB 86 of 2010

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment September 2010 - Specification Under Subsection 84AAA(2)


Amendment determination under subsection 84AAA(2) of the National Health Act 1953


I, Diana MacDonell, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.


Dated: 6 August 2010

Diana MacDonnell



Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing



Amendment determination — Pharmaceutical Benefits - Early Supply



1          Name of Instrument


(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment September 2010 - specification under subsection 84AAA(2).


(2)           This Instrument may also be cited as “No. PB 86 of 2010”.


2          Commencement


This Instrument commences on 1 September 2010.



3          Amendment of PB 30 of 2009


Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.


Schedule 1        Amendments

[1]                                  Schedule 1, item dealing with Vildagliptin

Omit from the columns in the order indicated:



Tablet 50 mg